Vanda Pharmaceuticals Stock Today
| VNDA Stock | USD 4.97 0.27 5.15% |
Performance9 of 100
| Odds Of DistressLess than 4
|
Vanda Pharmaceuticals is trading at 4.97 as of the 18th of April 2024, a -5.15 percent decrease since the beginning of the trading day. The stock's open price was 5.24. Vanda Pharmaceuticals has only four percent chance of going through some form of financial distress over the next 2 years but had a somewhat ok performance during the last 90 days. Equity ratings for Vanda Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of September 2022 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 12th of April 2006 | Category Healthcare | Classification Health Care |
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia. The company has 57.54 M outstanding shares of which 2.49 M shares are at this time shorted by private and institutional investors with about 2.78 trading days to cover. More on Vanda Pharmaceuticals
Moving against Vanda Stock
| 0.45 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
Vanda Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Vanda Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vanda Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Mihael Polymeropoulos | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Vanda Pharmaceuticals report their recommendations after researching Vanda Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Vanda Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Vanda Pharmaceuticals. The Vanda consensus assessment is calculated by taking the average forecast from all of the analysts covering Vanda Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Vanda Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Vanda Pharmaceuticals is doing better financially then in previous quarter. It has a moderate odds of reporting better financial numbers in May. Financial strength of Vanda Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vanda Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Vanda Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Vanda Pharmaceuticals' financial leverage. It provides some insight into what part of Vanda Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vanda Pharmaceuticals (VNDA) is traded on NASDAQ Exchange in USA. It is located in 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 and employs 203 people. Vanda Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 233.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vanda Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Vanda Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vanda Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 57.54 M outstanding shares of which 2.49 M shares are at this time shorted by private and institutional investors with about 2.78 trading days to cover.
Vanda Pharmaceuticals currently holds about 440.86 M in cash with 12.8 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.79, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Vanda Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationVanda Pharmaceuticals maintains a total of 57.54 Million outstanding shares. The majority of Vanda Pharmaceuticals outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Vanda Pharmaceuticals to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Vanda Pharmaceuticals. Please pay attention to any change in the institutional holdings of Vanda Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Vanda Ownership Details
Vanda Stock Price Odds Analysis
What are Vanda Pharmaceuticals' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Vanda Pharmaceuticals jumping above the current price in 90 days from now is near 1%. The Vanda Pharmaceuticals probability density function shows the probability of Vanda Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.0131. This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Vanda Pharmaceuticals will likely underperform. Additionally, vanda Pharmaceuticals has an alpha of 0.5273, implying that it can generate a 0.53 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Vanda Pharmaceuticals to move above the current price in 90 days from now is near 1 (This Vanda Pharmaceuticals probability density function shows the probability of Vanda Stock to fall within a particular range of prices over 90 days) .
Vanda Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Vanda Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vanda Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vanda Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2023-12-31 | 1.2 M | |
| State Street Corporation | 2023-12-31 | 1.2 M | |
| Millennium Management Llc | 2023-12-31 | 998.3 K | |
| Jacobs Levy Equity Management, Inc. | 2023-09-30 | 965.9 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 922.4 K | |
| Two Sigma Advisers, Llc | 2023-12-31 | 886.5 K | |
| Federated Hermes Inc | 2023-12-31 | 818 K | |
| Two Sigma Investments Llc | 2023-12-31 | 783 K | |
| Citadel Advisors Llc | 2023-09-30 | 684.2 K | |
| Blackrock Inc | 2023-12-31 | 8.3 M | |
| Renaissance Technologies Corp | 2023-12-31 | 3.7 M |
Vanda Pharmaceuticals Historical Income Statement
Vanda Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Vanda's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Vanda Pharmaceuticals revenue and expense. Vanda Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Vanda Pharmaceuticals' Cost Of Revenue is projected to increase significantly based on the last few years of reporting. The current year's Income Before Tax is expected to grow to about 6.7 M, whereas Depreciation And Amortization is forecasted to decline to about 2.8 M. View More FundamentalsVanda Stock Against Markets
Picking the right benchmark for Vanda Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Vanda Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Vanda Pharmaceuticals is critical whether you are bullish or bearish towards Vanda Pharmaceuticals at a given time. Please also check how Vanda Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vanda Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Vanda Pharmaceuticals Corporate Directors
Vanda Pharmaceuticals corporate directors refer to members of a Vanda Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Vanda Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Vanda Pharmaceuticals' board members must vote for the resolution. The Vanda Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Phaedra Chrousos | Independent Director | Profile | |
| Kenneth Bate | Director | Profile | |
| Richard Dugan | Independent Director | Profile | |
| Michael Cola | Independent Director | Profile |
How to buy Vanda Stock?
Before investing in Vanda Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Vanda Pharmaceuticals. To buy Vanda Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Vanda Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Vanda Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Vanda Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Vanda Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Vanda Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Vanda Stock please use our How to Invest in Vanda Pharmaceuticals guide.
Already Invested in Vanda Pharmaceuticals?
The danger of trading Vanda Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Vanda Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Vanda Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Vanda Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Vanda Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vanda Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vanda Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vanda Pharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vanda Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Vanda Stock refer to our How to Trade Vanda Stock guide.Note that the Vanda Pharmaceuticals information on this page should be used as a complementary analysis to other Vanda Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Vanda Stock analysis
When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Vanda Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vanda Pharmaceuticals. If investors know Vanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vanda Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.04 | Revenue Per Share 3.357 | Quarterly Revenue Growth (0.30) | Return On Assets (0.01) |
The market value of Vanda Pharmaceuticals is measured differently than its book value, which is the value of Vanda that is recorded on the company's balance sheet. Investors also form their own opinion of Vanda Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vanda Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vanda Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vanda Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vanda Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vanda Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vanda Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.